Home
Conditions
Hepatitis, Chronic

Clinical trial condition

Hepatitis, Chronic

Explore clinical trials studying Hepatitis, Chronic. Study availability and eligibility vary by location and protocol.

1,281 public trials 89 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis, Chronic trial results

Completed

Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients

NCT01581398

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: 302 Military Hospital Beijing, China

Beijing Youan Hospital, Capital Medical University Beijing, China

Beijing Youyi Hospital, capital Medical University Beijing, China

Peking University First Hospital Beijing, China

View all 42 locations

View Trial Details

Completed

Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection

NCT02254707

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients

NCT01197157

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: National Liver Institute Shebin El-Kom, Monufia Governorate, Egypt

View Trial Details

Completed

Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen

NCT00286871

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4

NCT01884402

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Fundación Pública Andaluza para la Gestión de la investigación en salud de Sevilla (FISEVI) Seville, Sevilla, Spain

Fundación Pública Andaluza para la Gestión de la investigación en salud de Sevilla (FISEVI) Seville, Spain

View Trial Details

Completed

Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.

NCT00323804

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +17 more
Locations: CHU Brugmann Brussels, Belgium

Hôpital Bracops Brussels, Belgium

Hôpital Erasme Brussels, Belgium

Hôpital de Jolimont La Louvière, Belgium

View all 45 locations

View Trial Details

Completed

Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C

NCT02226939

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations: Not specified

View Trial Details

Completed

Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection

NCT02226952

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Effect of High-protein High-fiber Diet in Patients With Autoimmune Hepatitis

NCT01655121

Conditions: Autoimmune Diseases, Autoimmune Hepatitis, Cirrhosis, +9 more
Locations: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, D.f., Mexico

View Trial Details

Completed

The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection

NCT00556504

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Chang Gung Memorial Hospital Taoyuan, Taiwan

View Trial Details

Hepatitis, Chronic

Hepatitis, Chronic trial results

Related conditions